I find it quite unbelievable the lack of news flow from this company onto the ASX.
I mean to say, even if they posted up a monthly news update as to how things are progressing it would be something. Instead we go searching here and there to find any snippets or hint of news.
Since the 18/3/16 we have had 2 updates released on ASX relating to their products:
1) 2/5/16 Cantrixil update
2) 14/6/16 Anisina patent
It's like the lights are on but no one is home when it come to the business side of things!!
Come on guys, smarten up and start to better inform your shareholders the right way. After all, it is our money you a playing with. Let's see a return on our investment and show that you actually care.
NRT Price at posting:
9.7¢ Sentiment: Buy Disclosure: Held